Kinross Gold Corp. is primarily involved in the exploration and operation of gold mines and also is a leading gold mining company globally. The company's operations are located in three core regions: the Americas and West Africa. It holds major assets in Canada, the United States and Russia, and is primarily involved in the exploration and operation of gold mines. Kinross also produces and sells silver. It runs several mines, including Fort Knox, Round Mountain and Kettle River-Buckhorn in the United States, Dvoinoye and Kupol in Russia, Maricunga in Chile, and Paracatu in Brazil. The company's development projects include La Coipa in Chile and Tasiast in Mauritania. Kinross acquired subsidiary, Kinross Brasil Mineracao and hydroelectric power plants (Barra dos Coqueiros and Cacu) located in Brazil from a subsidiary of Gerdau SA. Moreover, strategic investment in core asset will further enhance and strengthen Paracatu, which is a cornerstone asset in the company's portfolio....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 27 December 2025
2018-09-11 18:36:00 Tuesday ET

President Trump tweets that Apple can avoid tariff consequences by shifting its primary supply chain from China to America. These Trump tariffs on another $
2019-11-09 16:38:00 Saturday ET

Federal Reserve Chairman Jerome Powell indicates that the central bank would resume Treasury purchases to avoid turmoil in money markets. Powell indicates t
2017-10-27 06:35:00 Friday ET

Leon Cooperman, Chairman and CEO of Omega Advisors, points out that the current Trump stock market rally now approaches normalization. The U.S. stock market
2018-09-30 14:34:00 Sunday ET

Goldman, JPMorgan, Bank of America, Credit Suisse, Morgan Stanley, and UBS face an antitrust lawsuit. In this lawsuit, a U.S. judge alleges the illegal cons
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-07-31 11:34:00 Wednesday ET

AYA Analytica finbuzz podcast channel on YouTube July 2019 In this podcast, we discuss several topical issues as of July 2019: (1) All 18 systemical